v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Net loss $ (297,762) $ (413,386) $ (1,341)
Depreciation and amortization 32,055 12,952 80
Stock-based compensation 93,590 36,168 115
Deferred income taxes 32,203 (7,349) 0
Excess tax benefit on stock-based compensation (10,178) (32) (143)
Losses in equity interests 26,652 0 0
Non-cash interest expense 0 106 0
Acquisition-related expense (benefit) (4,537) 203,183 0
Gain on return of common stock (4,916) 0 0
Restricted cash (12,519) 0 0
Accounts receivable (70,376) (34,905) (601)
Prepaid expenses and other current assets (36,292) (2,467) (67)
Accounts payable (20,997) 50,835 182
Accrued merchant payable 380,108 149,044 4,305
Accrued expenses and other current liabilities 189,127 94,592 5,038
Due to related parties 347 (319) (20)
Other (6,058) (1,537) (38)
Net cash provided by operating activities 290,447 86,885 7,510
Purchases of property and equipment (43,811) (14,681) (290)
Acquisitions of businesses, net of acquired cash (14,400) 3,816 0
Purchases of intangible assets (14,517) (922) (271)
Changes in restricted cash 0 (92) (1,400)
Purchases of investments in subsidiaries (42,663) 0 0
Purchases of equity investments (32,042) 0 0
Net cash used in investing activities (147,433) (11,879) (1,961)
Proceeds from issuance of stock, net of issuance costs 1,266,392 584,658 29,946
Tax withholdings related to net shares settlements of restricted stock units (3,770) 0 0
Excess tax benefit on stock-based compensation 10,178 32 143
Loans from related parties 0 5,035 0
Repayments of loans to related parties (14,358) 0 0
Repurchase of common stock (353,768) (503,173) 0
Proceeds from exercise of stock options 3,008 195 72
Dividends paid on common and preferred stock 0 (1,299) (26,363)
Conversion of preferred stock 51 0 0
Partnership distribution (5,525) 0 0
Redemption of preferred stock (35,003) (55,003) 0
Net cash provided by financing activities 867,205 30,445 3,798
Effect of exchange rate changes on cash and cash equivalents (6,117) 1,069 0
Net increase in cash and cash equivalents 1,004,102 106,520 9,347
Cash and Cash Equivalents, beginning of year 118,833 12,313 2,966
Cash and Cash Equivalents, end of year 1,122,935 118,833 12,313
Income tax payments 1,635 140 0
Cash interest payments 0 287 0
Contingent consideration given in connection with acquisitions 17,755 63,180 0
Issuance of common stock in connection with acquisitions 11,067 80,200 0
Investments in equity interests 45,218 0 0
Stock issued in exchange for additional interests in majority owned subsidiary $ 10,400 $ 0 $ 0